VUNO Boasts of its AI Solutions and Research Results at RSNA 2021 – PRNewswire

VUNO will showcase four medical artificial intelligence solutions:VUNO Med-Chest X-Ray, VUNO MedLungCT AI,VUNO Med-DeepBrain andVUNO Med-BoneAge that can be seamlessly integrated with PACS(Picture Archiving and Communication System), EMR(Electronic Medical Record) systems or any medical devices. A virtual reading room linked to the PACS system will be set up in the VUNO booth so that visitorscan get a first-hand look at VUNO Med solutions that integrated with PACS.

VUNO will present the future R&D direction of VUNO at the AI Theater under the topic 'The Past, Present and the Future of VUNO Med for Precision Imaging.' Following that, nine research achievements will be presented at a research presentation session. It includes topics encompassing various medical imaging fields, such as MRI-based AI model in prediction of MCI to dementia, AI-aided diagnosis to diagnose lung nodule malignancy, basal lung metastasis in colon cancer patients.

Furthermore, VUNO will participate in IAIP (Imaging AI in Practice), a virtual demonstration program developed to effectively demonstrate the effects of AI solutions in clinical settings. The company will showcase VUNO MedLungCT AI on this program to demonstrate how it works by using real-world clinical scenarios.

Hyun-Jun Kim, CEO of VUNO said, "Through RSNA 2021 participation, we will introduce various clinical research achievements to global radiology officials using AI technology," Hyun-jun Kim, CEO of VUNO said, adding "we plan to expand our partnerships with overseas partner companies and medical institutions by offering an opportunity for participants to directly experience VUNO Med solutions."

SOURCE VUNO Inc.

Read the original here:

VUNO Boasts of its AI Solutions and Research Results at RSNA 2021 - PRNewswire